Cardiovascular 2 Anti-arrhythmics Flashcards
Drug class for Procainamide
class 1A Na channel
MoA for Procainamide
Decreases myocardial excitability and conduction velocity and may depress myocardial contractility, by increasing the electrical stimulation threshold of ventricle, His-Purkinje system and through direct cardiac effects (UtD)
Indications for Procainamide
life threatening ventricular arrhythmias
SE/ADRs for Procainamide
hypotension, N/V/D, SLE sxs, agranulocytosis (w/ prolonged use), QTc prolongation
Contra-indications for Procainamide
complete heart block, 2nd deg AV block, SLE, tornadoes de pointes
Dx-Dx interactions for Procainamide
other anti-arrhythmics
Monitoring for Procainamide
ECG, BP, eGFR, BUN, CBC, ANA titers, liver function, procainamide/NAPA conc (in liver disease)
PG category for Procainamide
PG C
Drug class for Lidocaine
class 1B Na channel
MoA for Lidocaine
blocks both the initiation and conduction of nerve impulses by decreasing the neuronal membrane’s permeability to sodium ions,suppresses automaticity of conduction tissue, by increasing electrical stimulation threshold of ventricle, His-Purkinje system, and spontaneous depolarization of the ventricles during diastole (UtD)
Indications for Lidocaine
suppression of existing ventricular arrhythmias
SE/ADRs for Lidocaine
arrhythmias, CV collapse, increase defib threshold, edema, heart block, hypotension, agitation, anxiety, metallic, taste, bronchospasm
Contra-indications for Lidocaine
severe SA, AV interventricular heart block w/out pacemaker, corn allergy
Dx-Dx interaction for Lidocaine
multiple (prolonged use)
Monitoring for Lidocaine
liver function, serum concentration, ECG, BP
PG category for Lidocaine
PG B
Drug class for Flecainide
class 1C Na channel
MoA for Flecainide
slows conduction in cardiac tissue by altering transport of ions across cell membranes; causes slight prolongation of refractory periods; increases electrical stimulation threshold of ventricle, His-Purkinje system
Indications for Flecainide
ventricular arrhythmias (prevention); PSVT (prevention); paroxysmal A fib/flutter
SE/ADRs for Flecainide
dizziness, blurred vision, dyspnea, palpitations, HA, pro-arrhythmic potential
Contra-indications for Flecainide
pre-existing 2 or 3 deg heart block, RBBB w/out pacemaker, cardiogenic shock
Dx-Dx interactions for Flecainide
multiple